Cysteamine Cream for Melasma: Does It Work?

Cysteamine cream for melasma can fade brown patches, but it works slowly. Most trials studied a 5% topical cream for about 8 to 16 weeks. It beat placebo and performed similarly to 4% hydroquinone when several small trials were pooled. That does not prove the two work equally well. Cysteamine is a reasonable alternative to discuss when you want to avoid hydroquinone or cannot tolerate it.

What cysteamine cream does

Cysteamine is a topical pigment-reducing active from a group of compounds called aminothiols. It interferes with melanin production, although its exact action in human skin is not fully settled. It is not an exfoliating acid, and it does not remove melasma's triggers.

The evidence applies mainly to 5% cysteamine used on clinician-diagnosed facial melasma. It cannot tell you whether an unidentified brown patch is melasma. Freckles, sun spots and post-inflammatory marks can look similar but need different plans. This guide to telling melasma from freckles and sun spots explains the visible clues and their limits.

What the clinical evidence shows

The best current summary is Milanesi and colleagues' 2026 meta-analysis. It combined five randomized trials with 193 patients; 97 received cysteamine. Short-term pigment improvement did not differ statistically between 5% cysteamine and 4% hydroquinone. Rates of redness, burning and itching also showed no clear difference.

That result means the studies did not detect a difference. It does not establish perfect equivalence. The authors flagged small samples, brief follow-up and inconsistent protocols, which leave long-term effectiveness uncertain. Some trials also used supplied products or had manufacturer ties, so independent replication matters.

The placebo evidence is clearer. Mansouri and colleagues randomized 50 people with epidermal melasma in 2015. Color readings improved more with 5% cysteamine by month two and again by month four. At four months, the Melasma Area and Severity Index was also lower than with placebo.

Head-to-head results are less tidy. Lima and colleagues studied 40 women for 120 days in 2020. The cysteamine group's modified severity score fell 24% at day 60 and 38% at day 120. Hydroquinone produced larger falls of 41% and 53%. Both groups used tinted SPF 50 sunscreen, so neither cream explains the full change.

The practical reading is simple. Cysteamine has real trial support, but it has not shown faster or more reliable fading than hydroquinone. Hydroquinone also has longer clinical use and different risks. If that comparison drives your choice, read the evidence behind why hydroquinone is restricted and how it works.

How long does cysteamine take to work?

Give it at least eight weeks before judging pigment change. Most useful trial endpoints came at 8, 12 or 16 weeks. Month four is a better decision point than day ten.

Track progress once every four weeks, not every morning. Use the same camera, room, distance and indirect daylight. Turn off beauty filters and automatic portrait effects. This is an editorial tracking method, not a validated medical test, but it reduces lighting noise.

A lighter patch in one photo proves little. Look for the same change across two comparable sessions. If the border, size and darkness stay unchanged after 12 to 16 weeks, ask whether the diagnosis, formula or plan needs review.

A decision table before you buy

When cysteamine fits, and when to pause

Your situation	What the evidence means	Sensible next step	Main limit
Melasma is confirmed and you want a non-hydroquinone topical	5% cysteamine beat placebo and had similar pooled short-term results to 4% hydroquinone.	Check the exact label and discuss it with a dermatologist if your melasma is persistent.	Trials were small and mostly lasted four months.
You want the fastest possible fading	Cysteamine has not proved faster. One 120-day trial favored hydroquinone on the clinician severity score.	Discuss established prescription options instead of assuming a cosmetic cream is quicker.	Speed varies with pigment depth, triggers and tolerance.
Your skin is already stinging, peeling or inflamed	Cysteamine can cause burning, redness, itching and dryness.	Settle the irritation and get advice before adding another active.	More irritation can make pigmentation harder to manage.
You already use retinoids, acids or prescription lighteners	Combination safety cannot be inferred from cysteamine-only trials.	Ask the prescriber how to separate or simplify the products.	Product formulas and contact times differ.
You are pregnant or breastfeeding	The key trials do not establish safety for this group.	Ask your clinician before using it, and do not copy a trial regimen.	One major comparative trial excluded pregnant participants.
The mark is new, changing, raised, scaly, bleeding or one-sided	Cysteamine trials enrolled people already diagnosed with melasma.	Get the patch examined before trying to fade it.	A cream cannot confirm what the mark is.

How to use cysteamine without creating more pigment

Follow your product's contact time exactly. The research does not support one universal schedule. Karrabi and colleagues tested 15-minute daily contact, while Lima's protocol increased contact from 15 minutes to two hours. Different bases can change delivery and irritation, so longer contact is not automatically better.

Keep the rest of the routine plain at first. Use a gentle cleanser, moisturizer and sunscreen. Do not stack cysteamine with a retinoid, strong acid, scrub or another lightener without label guidance or clinical advice. If you already use prescribed treatment, do not change it on your own.

Temporary stinging, redness, itching, dryness and a sulfur-like smell are the main drawbacks reported across studies. Persistent burning, swelling, blistering, marked peeling or darker patches are reasons to stop and seek advice. New darkening can mean the routine is irritating your skin.

Sun protection decides whether fading lasts

Cysteamine lowers pigment production; it does not switch off the light response that drives melasma. Daily broad-spectrum sunscreen, shade and a hat remain part of treatment. For visible-light protection, choose a tint that lists iron oxides and suits your skin tone.

Castanedo-Cazares and colleagues tested this point in 68 people with melasma in 2014. Everyone used 4% hydroquinone and SPF 50 or higher. Among 61 completers, the iron-oxide sunscreen group improved 15% more on the severity score than the UV-only group. The trial tested treatment support, not cysteamine or long-term relapse.

Our guide to tinted sunscreen with iron oxides for melasma explains how pigment adds visible-light coverage. The American Academy of Dermatology also advises SPF 30 or higher, shade and hats to help prevent return.

No good trial defines the best cysteamine maintenance schedule after fading. Do not assume daily use should continue forever. A dermatologist can decide whether to reduce frequency, change treatment or investigate a trigger.

When to choose another route

See a dermatologist if you are unsure it is melasma, irritation persists, or there is no clear change by month four. An appointment also makes sense when melasma returns despite steady light protection. The next plan may involve a prescription topical or a carefully selected combination.

Cysteamine is one option, not the default for everyone. If you are comparing pigment pathways, this evidence review of tranexamic acid for melasma and dark spots separates topical research from prescription oral treatment. Do not combine either approach without clinical guidance.